Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-01368-0002-0000-2 |
Chemical Name: | 2-Nitro-p-phenylenediamine |
CASRN: | 5307-14-2 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 186397_CA |
Study Result: | Positive |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Negative |
Induced Rat Liver S9 | 1_S9 | Weakly Positive |
No Activation | 2 | Negative |
Induced Rat Liver S9 | 2_S9 | Positive |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 2 | 0.020 | 2.0 | 1 | 0.010 | 1.0 | 1 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
Acetone | 0 | 100 | 6 | 0.060 | 4.0 | 1 | 0.010 | 1.0 | 5 | 0.050 | 3.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | 2-Nitro-p-phenylenediamine | 300 | 100 | 7 | 0.070 | 6.0 | 2 | 0.020 | 2.0 | 5 | 0.050 | 4.0 | 0 | 0.000 | 0.0 |
400 | 81 | 8 | 0.099 | 6.2 | 2 | 0.025 | 1.2 | 6 | 0.074 | 6.2 | 0 | 0.000 | 0.0 | ||
500 | 76 | 10 | 0.132 | 9.2 | 0 | 0.000 | 0.0 | 10 | 0.132 | 9.2 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.05 | 100 | 22 | 0.220 | 15.0 | 9 | 0.090 | 8.0 | 13 | 0.130 | 9.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.08 | 25 | 11 | 0.440 | 32.0 | 3 | 0.120 | 8.0 | 8 | 0.320 | 24.0 | 0 | 0.000 | 0.0 | |
Trend: | 1.335 | -0.674 | 1.893 | ||||||||||||
Probability: | 0.091 | 0.750 | 0.029 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 100 | 4 | 0.040 | 4.0 | 0 | 0.000 | 0.0 | 4 | 0.040 | 4.0 | 0 | 0.000 | 0.0 |
Acetone | 0 | 100 | 3 | 0.030 | 3.0 | 1 | 0.010 | 1.0 | 2 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | 2-Nitro-p-phenylenediamine | 300 | 100 | 11 | 0.110 | 8.0 | 3 | 0.030 | 3.0 | 8 | 0.080 | 6.0 | 0 | 0.000 | 0.0 |
400 | 100 | 12 | 0.120 | 9.0 | 7 | 0.070 | 6.0 | 5 | 0.050 | 4.0 | 0 | 0.000 | 0.0 | ||
500 | 100 | 25 | 0.250 | 17.0 | 13 | 0.130 | 11.0 | 12 | 0.120 | 8.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 7.5 | 100 | 10 | 0.100 | 8.0 | 1 | 0.010 | 1.0 | 9 | 0.090 | 8.0 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 37.5 | 25 | 14 | 0.560 | 36.0 | 5 | 0.200 | 16.0 | 9 | 0.360 | 24.0 | 0 | 0.000 | 0.0 | |
Trend: | 3.269 | 3.282 | 1.594 | ||||||||||||
Probability: | 0.001 | 0.001 | 0.055 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 200 | 10 | 0.050 | 4.5 | 6 | 0.030 | 3.0 | 4 | 0.020 | 2.0 | 0 | 0.000 | 0.0 |
Acetone | 0 | 200 | 11 | 0.055 | 4.5 | 6 | 0.030 | 3.0 | 5 | 0.025 | 2.0 | 0 | 0.000 | 0.0 | |
Test Chemical: | 2-Nitro-p-phenylenediamine | 300 | 114 | 15 | 0.132 | 10.5 | 4 | 0.035 | 3.5 | 11 | 0.096 | 7.9 | 0 | 0.000 | 0.0 |
400 | 200 | 20 | 0.100 | 9.0 | 6 | 0.030 | 2.5 | 14 | 0.070 | 6.5 | 0 | 0.000 | 0.0 | ||
500 | 200 | 20 | 0.100 | 7.5 | 2 | 0.010 | 1.0 | 18 | 0.090 | 7.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.05 | 200 | 35 | 0.175 | 15.0 | 11 | 0.055 | 5.5 | 24 | 0.120 | 10.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.08 | 25 | 11 | 0.440 | 32.0 | 2 | 0.080 | 4.0 | 9 | 0.360 | 32.0 | 0 | 0.000 | 0.0 | |
Trend: | 1.092 | -1.346 | 2.037 | ||||||||||||
Probability: | 0.137 | 0.911 | 0.021 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 200 | 12 | 0.060 | 5.0 | 6 | 0.030 | 2.5 | 6 | 0.030 | 3.0 | 0 | 0.000 | 0.0 |
Acetone | 0 | 200 | 5 | 0.025 | 2.5 | 0 | 0.000 | 0.0 | 5 | 0.025 | 2.5 | 0 | 0.000 | 0.0 | |
Test Chemical: | 2-Nitro-p-phenylenediamine | 300 | 200 | 23 | 0.115 | 8.5 | 15 | 0.075 | 6.5 | 8 | 0.040 | 2.5 | 0 | 0.000 | 0.0 |
400 | 200 | 27 | 0.135 | 12.0 | 13 | 0.065 | 5.5 | 14 | 0.070 | 6.5 | 0 | 0.000 | 0.0 | ||
500 | 200 | 28 | 0.140 | 11.5 | 11 | 0.055 | 5.5 | 17 | 0.085 | 7.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 7.5 | 200 | 29 | 0.145 | 13.0 | 8 | 0.040 | 4.0 | 21 | 0.105 | 9.0 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 37.5 | 25 | 24 | 0.960 | 64.0 | 10 | 0.400 | 40.0 | 14 | 0.560 | 44.0 | 0 | 0.000 | 0.0 | |
Trend: | 3.484 | 2.407 | 2.670 | ||||||||||||
Probability: | 0.000 | 0.008 | 0.004 |